Oncotarget

Corrections:

Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer

PDF  |  How to cite

Oncotarget. 2019; 10:917-917. https://doi.org/10.18632/oncotarget.26650

Metrics: PDF 553 views  |   ?  

Barbara Adamo1,*, Giuseppina Rosaria Rita Ricciardi2,*, Antonio Ieni3, Tindara Franchina2, Carmine Fazzari4, Maria Vita Sanò5, Giuseppe Angelico6, Michele Caruso5, Giovanni Tuccari3 and Vincenzo Adamo2

1 Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain
2 Medical Oncology Unit A.O. Papardo & Department of Human Pathology University of Messina, Messina, Italy
3 Department of Human Pathology of Adult and Evolutive Age “Gaetano Barresi”, Section of Pathology, University of Messina, AOU Policlinico ”G. Martino“ Messina, Italy
4 Pathology Unit, Humanitas Center of Oncology, Catania, Italy
5 Medical Oncology, Humanitas Catania Oncology Center, Catania, Italy
6 G. F. Ingrassia Department, Section of Anatomic Pathology, University Hospital “Policlinico-Vittorio Emanuele”, Catania, Italy
* These authors have contributed equally to this work

Published: January 25, 2019

This article has been corrected: The correct author name and author contributed information is given below:

Barbara Adamo1,*, Giuseppina Rosaria Rita Ricciardi2,*, Antonio Ieni3, Tindara Franchina2, Carmine Fazzari4, Maria Vita Sanò5, Giuseppe Angelico6, Michele Caruso5, Giovanni Tuccari3 and Vincenzo Adamo2

* These authors have contributed equally to this work

Original article: Oncotarget. 2017; 8:76974-76986. DOI: https://doi.org/10.18632/oncotarget.20293.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26650